In a 2023 survey measuring the attitudes of stakeholders, CGT innovators and health care providers, it was found that the majority of the respondents had positive or very positive sentiments towards development and commercialization of cell and gene therapies. Regarding future expectations, ** percent of the respondents had very positive sentiments, compared to ** percent regarding the past 12–18 months.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Deloitte. (April 3, 2023). Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1548812/attitudes-towards-cell-and-gene-therapies-us/
Deloitte. "Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023." Chart. April 3, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1548812/attitudes-towards-cell-and-gene-therapies-us/
Deloitte. (2023). Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1548812/attitudes-towards-cell-and-gene-therapies-us/
Deloitte. "Distribution of Attitudes towards The Development and Commercialization of Cell and Gene Therapies in The past and near Future as of 2023." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 3 Apr 2023, /statistics/1548812/attitudes-towards-cell-and-gene-therapies-us/
Deloitte, Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023 ÌÇÐÄÆƽâ°æ, /statistics/1548812/attitudes-towards-cell-and-gene-therapies-us/ (last visited July 31, 2026)
Distribution of attitudes towards the development and commercialization of cell and gene therapies in the past and near future as of 2023 [Graph], Deloitte, April 3, 2023. [Online]. Available: /statistics/1548812/attitudes-towards-cell-and-gene-therapies-us/
